Current Pharmaceutical Biotechnology
Title:Editorial (Thematic Issue: Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. International Cooperation, Translational Research and Transdisciplinarity)
Volume: 18 Issue: 1
Author(s): David M. Dohan Ehrenfest, Lidia M. Wisniewska, Agata Cieslik-Bielecka, Hom-Lay Wang and Manuel Fernandes-Cruz
Affiliation:
Export Options
About this article
Cite this article as:
Dohan Ehrenfest M. David, Wisniewska M. Lidia, Cieslik-Bielecka Agata, Wang Hom-Lay and Fernandes-Cruz Manuel, Editorial (Thematic Issue: Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. International Cooperation, Translational Research and Transdisciplinarity), Current Pharmaceutical Biotechnology 2017; 18 (1) . https://dx.doi.org/10.2174/1389201018666170104110436
DOI https://dx.doi.org/10.2174/1389201018666170104110436 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Controlling HIV-1 Rev Function
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter
Current Enzyme Inhibition Colchicine: An Ancient Drug with Multiple Benefits
Current Pharmaceutical Design Voltammetric Sensing of Bilirubin Based on Nafion/Electrochemically Reduced Graphene Oxide Composite Modified Glassy Carbon Electrode
Current Analytical Chemistry Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
CNS & Neurological Disorders - Drug Targets Structural Studies of the Klentaq1 DNA Polymerase
Current Organic Chemistry Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Glucose Transporters Regulation on Ischemic Brain: Possible Role as Therapeutic Target
Central Nervous System Agents in Medicinal Chemistry Pharmaceutical Care: Past, Present and Future
Current Pharmaceutical Design Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
CNS & Neurological Disorders - Drug Targets Development of Ubiquitin Tools for Studies of Complex Ubiquitin Processing Protein Machines
Current Organic Chemistry Brain Permeable Nanoparticles
Recent Patents on CNS Drug Discovery (Discontinued) Acitretin Loaded Nanocarrier Gel: Formulation and Exploration of <i>In-vitro</i> Release Kinetics
Current Nanomedicine Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
Current Clinical Pharmacology Quinoline Derivatives: Candidate Drugs for a Class B G-Protein Coupled Receptor, the Calcitonin Gene-Related Peptide Receptor, a Cause of Migraines
CNS & Neurological Disorders - Drug Targets Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects
Current Pharmacogenomics Microwave Accelerated Labeling Methods in the Synthesis of Radioligands for Positron Emission Tomography Imaging
Current Radiopharmaceuticals Is Mental Practice an Effective Adjunct Therapeutic Strategy for Upper Limb Motor Restoration After Stroke? A Systematic Review and Meta- Analysis
CNS & Neurological Disorders - Drug Targets